1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2;Lancet,1988
2. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction;Lancet,1990
3. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin;Lancet,1990
4. Fibrinogen as a risk factor for stroke and myocardial infarction;Wilhelmsen;N. Engl. J. Med.,1984
5. Plasma fibrinogen — a major coronary risk factor;Stone;J. R. Coll. Gen. Pract.,1985